实用肝脏病杂志 ›› 2020, Vol. 23 ›› Issue (5): 678-681.doi: 10.3969/j.issn.1672-5069.2020.05.019

• 新生儿黄疸 • 上一篇    下一篇

蓝光联合腺苷蛋氨酸治疗新生儿黄疸疗效研究

黄晶, 彭秀春, 唐艳林   

  1. 432000 湖北省孝感市 武汉科技大学附属孝感医院/孝感市中心医院检验科(黄晶,唐艳林);
    中心血站输血科(彭秀春)
  • 出版日期:2020-09-10 发布日期:2020-09-11
  • 通讯作者: 彭秀春,E-mail:zhongguojiayou88@126.com
  • 作者简介:黄晶,女,32岁,大学本科,检验师。E-mail:hhhj2020@yeah.net
  • 基金资助:
    湖北省自然科学基金资助项目(编号:2019368)

Efficacy of adenosylmethionine and blue light treatment in neonatal jaundice

Huang Jing, Peng Xiuchun, Tang Yanlin.   

  1. Department of Clinical Laboratory, Xiaogan Central Hospital, Wuhan University of Science and Technology,Xiaogan 432000, Hubei Province, China
  • Online:2020-09-10 Published:2020-09-11

摘要: 目的 探讨蓝光联合腺苷蛋氨酸治疗新生儿黄疸的疗效。方法 2017年5月~2019年5月我院诊治的新生儿黄疸患儿196例,采用随机数字表法将所选患儿分为对照组(n=98)和观察组(n=98)。在对照组患儿,给予蓝光照射治疗,观察组患儿在对照组治疗的基础上给予丁二磺酸腺苷蛋氨酸肠溶片研磨成粉喂服治疗,两组患儿均连续治疗1 w,随访1 w。结果 在随访1 w末,观察组血清丙氨酸氨基转移酶(ALT)水平为(37.1±12.6)U/L,与对照组的【(41.9±11.3)U/L,P>0.05】比,无显著差异,血清天冬氨酸氨基转移酶(AST)水平为(36.2±11.6)U/L,与对照组的【(45.1±13.7)U/L,P>0.05】比,无显著差异,但血清总胆红素(TBIL)水平为(31.2±3.7)μmol/L,显著低于对照组【(62.5±7.1)μmol/L,P<0.05】;血清CRP水平为(8.6±1.3)U/L,显著低于对照组【(11.3±1.9)U/L,P<0.05】,血清磷酸肌酸激酶(CK)水平为(177.7±61.7)U/L,显著低于对照组【(209.6±72.1)U/L,P<0.05】,血清肌钙蛋白激酶同工酶(CK-MB)水平为(3.8±0.4)U/L,显著低于对照组【(5.4±0.9)U/L,P<0.05】,血清乳酸脱氢酶(LDH)水平为(350.5±103.1)U/L,显著低于对照组【(392.6±120.2)U/L,P<0.05】,而血清TRF水平为(1964.8±91.6)U/L,显著高于对照组【(1687.9±88.2)U/L,P<0.05】;观察组不良反应发生率为11.2%,与对照组的14.3%比,无显著性差异(P>0.05)。结论 应用腺苷蛋氨酸辅助蓝光治疗新生儿黄疸可加快黄疸消退,显著改善患儿心肌酶谱改变。

关键词: 新生儿黄疸, 丁二磺酸腺苷蛋氨酸, 蓝光, 心肌酶, 治疗 ,  ,  

Abstract: Objective The aim of this study was to investigate the efficacy of adenosylmethionine and blue light treatment in neonatal jaundice. Methods 196 children with neonatal jaundice were treated in our hospital between May 2017 and May 2019, and they were divided randomly into control (n=98) and observation group (n=98). The neonates in the control group were given blue light illumination (BLI), and those in the observation group were treated with adenosylmethionine succinate enteric-coated tablets and BLI combination for one week. All the children were followed-up for one week. Serum transferrin (TRF) and C-reactive protein (CRP), creatine kinase (CK) , creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH) levels were detected. Results At the end of one week follow-up, in the combination group, serum alanine aminotransferase (ALT) level was (37.1±12.6) U/L, significantly lower than in the control group , serum aspartate aminotransferase (AST) level was(36.2±11.6)U/L, not significantly different as compared to 【(45.1±13.7)U/L, P>0.05】 in the control, while serum bilirubin level was (31.2±3.7) μmol/L, significantly lower than 【(62.5±7.1)μmol/L, P<0.05】 in the control; serum CRP level was (8.6±1.3)U/L, much lower than 【(11.3±1.9)U/L, P<0.05】, serum CK level was (177.7±61.7)U/L, significantly lower than 【(209.6±72.1)U/L, P<0.05】, serum CK-MB level was (3.8±0.4)U/L, significantly lower than 【(5.4±0.9)U/L, P<0.05】, serum LDH level was (350.5±103.1)U/L, significantly lower than 【(392.6±120.2) U/L, P<0.05】, while serum TRF level was (1964.8±91.6)U/L, significantly higher than 【(1687.9±88.2)U/L, P<0.05】 in the control; the incidence of adverse reactions in the observation group was 11.2%, not significantly different as compared to 14.3% (P<0.05) in the control group. Conclusion The administration of adenosine methionine might assist subside jaundice in neonates at the base of BLI treatment, which needs further investigation.

Key words: Neonatal jaundice, Adenosylmethionine succinate enteric-coated tablets, Blue light , Myocardial enzymes, Therapy